Similarly, exenatide (Byetta and Bydureon) has shown modest weight-loss effectiveness, with fewer overall pounds lost compared to what patients typically achieve with Ozempic
At Stanton Chase, we're more than just an executive search and leadership consulting firm
The consumer products sector has historically produced its chief executives through a clear pathway: brand management, then category leadership, then P&L ownership
Tirzepatide: A review in type 2 diabetes
While most adults who have taken GLP-1 drugs say their insurance covered at least a part of the cost of these drugs, about a quarter (27%) of users with health insurance say they paid the full cost of the drugs themselves
heart disease, such as coronary heart disease and hypertension